Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
- PMID: 19455247
- PMCID: PMC2675836
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Abstract
Background: Epidermal growth factor receptor (EGFR) overexpression is observed in significant proportions of non-small cell lung carcinomas (NSCLC). Furthermore, overactivation of vascular endothelial growth factor (VEGF) leads to increased angiogenesis implicated as an important factor in vascularization of those tumors.
Patients and methods: Using tissue microarray technology, forty-paraffin (n = 40) embedded, histologically confirmed primary NSCLCs were cored and re-embedded into a recipient block. Immunohistochemistry was performed for the determination of EGFR and VEGF protein levels which were evaluated by the performance of computerized image analysis. EGFR gene amplification was studied by chromogenic in situ hybridization based on the use of EGFR gene and chromosome 7 centromeric probes.
Results: EGFR overexpression was observed in 23/40 (57.5%) cases and was correlated to the stage of the tumors (p = 0.001), whereas VEGF was overexpressed in 35/40 (87.5%) cases and was correlated to the stage of the tumors (p = 0.005) and to the smoking history of the patients (p = 0.016). Statistical significance was assessed comparing the protein levels of EGFR and VEGF (p = 0.043, k = 0.846). EGFR gene amplification was identified in 2/40 (5%) cases demonstrating no association to its overall protein levels (p = 0.241), whereas chromosome 7 aneuploidy was detected in 7/40 (17.5%) cases correlating to smoking history of the patients (p = 0.013).
Conclusions: A significant subset of NSCLC is characterized by EGFR and VEGF simultaneous overexpression and maybe this is the eligible target group for the application of combined anti-EGFR/VEGF targeted therapies at the basis of genetic deregulation (especially gene amplification for EGFR).
Keywords: Non-small cell lung carcinoma; epidermal growth factor receptor; genes; tissue microarrays; vascular endothelial growth factor.
Figures


Similar articles
-
Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis.J BUON. 2010 Jan-Mar;15(1):107-15. J BUON. 2010. PMID: 20414936
-
Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays.Pathol Oncol Res. 2009 Sep;15(3):511-20. doi: 10.1007/s12253-008-9146-5. Pathol Oncol Res. 2009. PMID: 19145479
-
EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.Hepatogastroenterology. 2006 May-Jun;53(69):452-7. Hepatogastroenterology. 2006. PMID: 16795991
-
Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis.In Vivo. 2017 Jul-Aug;31(4):641-648. doi: 10.21873/invivo.11106. In Vivo. 2017. PMID: 28652432 Free PMC article.
-
Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).Rev Recent Clin Trials. 2006 Jan;1(1):1-13. doi: 10.2174/157488706775246157. Rev Recent Clin Trials. 2006. PMID: 18393776 Review.
Cited by
-
Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.PLoS One. 2015 Sep 30;10(9):e0139285. doi: 10.1371/journal.pone.0139285. eCollection 2015. PLoS One. 2015. PMID: 26422603 Free PMC article.
-
Notch 1 Receptor, Delta 1 Ligand and HES 1 Transcription Factor are Expressed in the Lining Epithelium of Periapical Cysts (Preliminary Study).Open Dent J. 2010 Jul 27;4:153-8. doi: 10.2174/1874210601004010153. Open Dent J. 2010. PMID: 21116324 Free PMC article.
References
-
- Argiris A, Hensing T, et al. Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. J. Thorac. Oncol. 2006;1:52–60. - PubMed
-
- Barder TD, Volgenstein B, et al. Somatic mutations of EGFR in colorectal cancers and glioblastomas. N. Engl. J. Med. 2004;351:2883–89. - PubMed
-
- Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J. Clin. Oncol. 2006;23:2445–59. - PubMed
-
- Baselga J, Pfister D, et al. Phase I studies of antiepidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J. Clin. Oncol. 2000;18:904–14. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous